Low-cost malaria drugs

Anti malaria drugs, more powerful than previous versions, will be put within reach of millions of people in Africa and Asia as part of an initiative launched by the UN-backed fund that fights major epidemics.
Malaria is a potentially deadly disease that is transmitted through mosquito bites and kills more than 2,ooo children every day.Children make up nearly 90 percent of the nearly one million people who die from malaria every year, mainly in sub-Saharan Africa and parts of Asia.The new drugs, known as "artemisinin combination therapies" or ACTs, are currently 10-40 times more expensive than the old ones which have lost their effectiveness because the malaria parasite has developed resistence to them.
Malaria affects 300-500 million people worldwide, leading to more than a million deaths. It is caused by the Plasmodium parasite which needs both humans and female Anopheles mosquitoes to propagate itself.